Literature DB >> 18467430

Thymidine kinase 2 (H126N) knockin mice show the essential role of balanced deoxynucleotide pools for mitochondrial DNA maintenance.

Hasan O Akman1, Beatriz Dorado, Luis C López, Angeles García-Cazorla, Maya R Vilà, Lauren M Tanabe, William T Dauer, Eduardo Bonilla, Kurenai Tanji, Michio Hirano.   

Abstract

Mitochondrial DNA (mtDNA) depletion syndrome (MDS), an autosomal recessive condition, is characterized by variable organ involvement with decreased mtDNA copy number and activities of respiratory chain enzymes in affected tissues. MtDNA depletion has been associated with mutations in nine autosomal genes, including thymidine kinase (TK2), which encodes a ubiquitous mitochondrial protein. To study the pathogenesis of TK2-deficiency, we generated mice harboring an H126N Tk2 mutation. Homozygous Tk2 mutant (Tk2(-/-)) mice developed rapidly progressive weakness after age 10 days and died between ages 2 and 3 weeks. Tk2(-/-) animals showed Tk2 deficiency, unbalanced dNTP pools, mtDNA depletion and defects of respiratory chain enzymes containing mtDNA-encoded subunits that were most prominent in the central nervous system. Histopathology revealed an encephalomyelopathy with prominent vacuolar changes in the anterior horn of the spinal cord. The H126N TK2 mouse is the first knock-in animal model of human MDS and demonstrates that the severity of TK2 deficiency in tissues may determine the organ-specific phenotype.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18467430      PMCID: PMC3115590          DOI: 10.1093/hmg/ddn143

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  37 in total

Review 1.  What regulates mitochondrial DNA copy number in animal cells?

Authors:  C T Moraes
Journal:  Trends Genet       Date:  2001-04       Impact factor: 11.639

2.  Late-onset mitochondrial DNA depletion: DNA copy number, multiple deletions, and compensation.

Authors:  C Barthélémy; H Ogier de Baulny; J Diaz; M A Cheval; P Frachon; N Romero; F Goutieres; M Fardeau; A Lombès
Journal:  Ann Neurol       Date:  2001-05       Impact factor: 10.422

Review 3.  In vivo and in organello assessment of OXPHOS activities.

Authors:  Antoni Barrientos
Journal:  Methods       Date:  2002-04       Impact factor: 3.608

4.  Selective muscle fiber loss and molecular compensation in mitochondrial myopathy due to TK2 deficiency.

Authors:  Maya R Vilà; Joan Villarroya; Elena García-Arumí; Amparo Castellote; Anna Meseguer; Michio Hirano; Manuel Roig
Journal:  J Neurol Sci       Date:  2007-11-19       Impact factor: 3.181

5.  Mutant mitochondrial thymidine kinase in mitochondrial DNA depletion myopathy.

Authors:  A Saada; A Shaag; H Mandel; Y Nevo; S Eriksson; O Elpeleg
Journal:  Nat Genet       Date:  2001-11       Impact factor: 38.330

6.  The deoxyguanosine kinase gene is mutated in individuals with depleted hepatocerebral mitochondrial DNA.

Authors:  H Mandel; R Szargel; V Labay; O Elpeleg; A Saada; A Shalata; Y Anbinder; D Berkowitz; C Hartman; M Barak; S Eriksson; N Cohen
Journal:  Nat Genet       Date:  2001-11       Impact factor: 38.330

Review 7.  Defects of intergenomic communication: autosomal disorders that cause multiple deletions and depletion of mitochondrial DNA.

Authors:  M Hirano; R Marti; C Ferreiro-Barros; M R Vilà; S Tadesse; Y Nishigaki; I Nishino; T H Vu
Journal:  Semin Cell Dev Biol       Date:  2001-12       Impact factor: 7.727

8.  Recessive Twinkle mutations in early onset encephalopathy with mtDNA depletion.

Authors:  Anna H Hakonen; Pirjo Isohanni; Anders Paetau; Riitta Herva; Anu Suomalainen; Tuula Lönnqvist
Journal:  Brain       Date:  2007-10-05       Impact factor: 13.501

9.  Deficiency of the alpha subunit of succinate-coenzyme A ligase causes fatal infantile lactic acidosis with mitochondrial DNA depletion.

Authors:  Elsebet Ostergaard; Ernst Christensen; Elisabeth Kristensen; Bodil Mogensen; Morten Duno; Eric A Shoubridge; Flemming Wibrand
Journal:  Am J Hum Genet       Date:  2007-06-04       Impact factor: 11.025

10.  Measurements of ATP in mammalian cells.

Authors:  Giovanni Manfredi; Lichuan Yang; Carl D Gajewski; Marina Mattiazzi
Journal:  Methods       Date:  2002-04       Impact factor: 3.608

View more
  48 in total

Review 1.  The clinical maze of mitochondrial neurology.

Authors:  Salvatore DiMauro; Eric A Schon; Valerio Carelli; Michio Hirano
Journal:  Nat Rev Neurol       Date:  2013-07-09       Impact factor: 42.937

2.  Deoxycytidine and Deoxythymidine Treatment for Thymidine Kinase 2 Deficiency.

Authors:  Carlos Lopez-Gomez; Rebecca J Levy; Maria J Sanchez-Quintero; Martí Juanola-Falgarona; Emanuele Barca; Beatriz Garcia-Diaz; Saba Tadesse; Caterina Garone; Michio Hirano
Journal:  Ann Neurol       Date:  2017-05-04       Impact factor: 10.422

Review 3.  Mitochondrial Diseases Part III: Therapeutic interventions in mouse models of OXPHOS deficiencies.

Authors:  Susana Peralta; Alessandra Torraco; Luisa Iommarini; Francisca Diaz
Journal:  Mitochondrion       Date:  2015-01-29       Impact factor: 4.160

4.  Zidovudine induces downregulation of mitochondrial deoxynucleoside kinases: implications for mitochondrial toxicity of antiviral nucleoside analogs.

Authors:  Ren Sun; Staffan Eriksson; Liya Wang
Journal:  Antimicrob Agents Chemother       Date:  2014-09-02       Impact factor: 5.191

Review 5.  The emerging role of immune dysfunction in mitochondrial diseases as a paradigm for understanding immunometabolism.

Authors:  Senta M Kapnick; Susan E Pacheco; Peter J McGuire
Journal:  Metabolism       Date:  2017-11-21       Impact factor: 8.694

Review 6.  Mitochondrial transcription: lessons from mouse models.

Authors:  Susana Peralta; Xiao Wang; Carlos T Moraes
Journal:  Biochim Biophys Acta       Date:  2011-11-18

Review 7.  Mouse models of mitochondrial DNA defects and their relevance for human disease.

Authors:  Henna Tyynismaa; Anu Suomalainen
Journal:  EMBO Rep       Date:  2009-01-16       Impact factor: 8.807

Review 8.  Mitochondrial Diseases Part II: Mouse models of OXPHOS deficiencies caused by defects in regulatory factors and other components required for mitochondrial function.

Authors:  Luisa Iommarini; Susana Peralta; Alessandra Torraco; Francisca Diaz
Journal:  Mitochondrion       Date:  2015-01-29       Impact factor: 4.160

9.  Early-onset liver mtDNA depletion and late-onset proteinuric nephropathy in Mpv17 knockout mice.

Authors:  Carlo Viscomi; Antonella Spinazzola; Marco Maggioni; Erika Fernandez-Vizarra; Valeria Massa; Claudio Pagano; Roberto Vettor; Marina Mora; Massimo Zeviani
Journal:  Hum Mol Genet       Date:  2008-09-24       Impact factor: 6.150

10.  Quantitation of cellular deoxynucleoside triphosphates.

Authors:  Paola Ferraro; Elisa Franzolin; Giovanna Pontarin; Peter Reichard; Vera Bianchi
Journal:  Nucleic Acids Res       Date:  2009-12-11       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.